✦ LIBER ✦

NP3 A COST-UTILITY MODEL OF TREATMENT OF NEWLY DIAGNOSED EPILEPSY IN GERMANY COMPARING TOPIRAMATE, CARBAMAZEPINE AND VALPROATE

✍ Scribed by E Remák; B Steinhoff

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PNP8: A MARKOV MODEL OF TREATMENT OF NEW

✍ E Remak; J Hutton; M Price; K Peeters; I Adriaenssen 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

An Economic Appraisal of Carbamazepine,

✍ Dominic C. Heaney; Simon D. Shorvon; Josemir W. A. S. Sander 📂 Article 📅 1998 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 615 KB

Economic analysis of epilepsy treatment:

✍ A. Shakespeare; G. Simeon 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 538 KB

PNL17 A COST-UTILITY MODEL COMPARING AZI

✍ J Hudry; J Rinne; T Keränen; L Eckert; J Cochran; C François 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB